Table 2. Ophthalmic screening: Electrophysiology of subjects included in the analyses.
| min | max | mean | SD | n | |
|---|---|---|---|---|---|
| pVEP 15’ P100latency (ms) | 106 | 151 | 123 | 10 | 41 |
| pVEP 15’ P100-N75amplitude (μV) | 2.5 | 28 | 10 | 5.9 | 41 |
| pVEP 15’ P100-N135amplitude (μV) | 1.6 | 25 | 11 | 6.1 | 41 |
| pVEP 60’ P100latency (ms) | 99 | 134 | 112 | 7.3 | 41 |
| pVEP 60’ P100-N75 amplitude (μV) | 1.2 | 24 | 7.8 | 4.2 | 41 |
| pVEP 60’ P100-N135 amplitude (μV) | 3.7 | 32 | 12 | 5.7 | 41 |
| mERGavg N1latency (ms) | 14 | 19 | 16 | 1.2 | 41 |
| mERGavg P1latency (ms) | 32 | 53 | 37 | 2.9 | 41 |
| mERGavg N1 –P1amplitude (μV) | 0.3 | 1.3 | 0.7 | 0.2 | 41 |
mERGavg = averaged multifocal electroretinogram, N1 = first trough, N75 = trough at 75 ms, N135 = trough at 135 ms, pVEP = pattern visual evoked potential, P1 = first peak, P100 = peak at 100 ms.